Tateishi U, Hasegawa T, Satake M, et al. Gastrointestinal stromal tumors. Correlation of computed tomography findings with tumor and mortality[J]. J Comput Asssist Tomogr, 2003, 27(5): 792-798.
[2]
Patel SR, Benjamin RS. Management of peritoneal and hepatic metastases from gastrointestinalstromal tumors[J]. Surg Oncol, 2000(9): 67-70.
[3]
Sandrasegaran K, Rajesh A, Rushing DA, et al. gastrointestinal stromal tumors: CT and MRI findings[J]. Eur Raadiol, 2005, 15(7): 1407-1414.
Yang TH, Hwang JI, Yang MS, et al. Gastrointestinal stromal tumors: computed features and prediction of malignant risk from computed tomographic imaging[J]. Chin Med Assoe, 2007, 70(9): 367-373.
Yeh CN, Chen TW, Wu TJ, et al. Treatment of patients with advanced gastrointestinal stromal tumor of smallbowel: implications of imatinib mesylate[J]. World J Gastroenterol, 2006, 12(23): 3760-3765.
van Roggen JF, van Velthuysen ML, Hogendoorn PC. The histopathological differential diagnosis of gastrointestinal stromal tumors[J]. J Clin Pathol, 2001, 54(2): 96-102.
[13]
Lee HE, Kim MA, Lee HS, et al. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining[J]. J Clin Pathol, 2008, 61(6): 722-729.
[14]
Mettinen M, Makhlouf H, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up[J]. Am J Surg Pathol, 2006, 30(4): 477-489.
Levy AD, Remotti H E, Thomp son WM, et al. Gastrointe-stinal stromal tumors: radiologic features with pathological correlation[J]. Radio Graphics, 2003, 23(2): 283-304.
[17]
Sandrasegaran K, Rajesh A, Rydberg J, et al. gastrointestinal stromal tumors: clincical, radiological and pathologic features[J]. AJR, 2005, 184(3): 803-811.
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J]. Hum Pathol, 2008, 39(10): 1411-1419.
[20]
Nillson B, Bümming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population study in western Sweden[J]. Cancer, 2005, 103(4): 821-829.
[21]
Rimondini A, Belgrano M, Favretto G, et al. Contribution of CT to Treatment Planning in Patients with GIST[J]. Radiol Med, 2007, 112(10): 691-702.